The US Farm Tire Market Report: 2011 Edition | Market Research Reports | 2016 : Market Databook || Road Infrastructure Construction in Mexico to 2016 | announces, a new market research report is available in its vast collection:

Cardiac Marker Diagnostic Testing Markets

( Company announces 15% discount on this report )

Cardiac marker diagnostic testing measures the concentration of certain proteins, i.e., biomarkers, which indicate the presence or severity of cardiovascular disease (CVD). Among the most prevalent CVDs are sudden cardiac arrest (SCA), acute myocardial infarction (AMI), congestive heart failure (CHF) and atherosclerosis. Every year, an estimated 17 million people worldwide die from a CVD. This TriMark Publications report describes the specific market segment of the in vitro diagnostics (IVD) market devoted to cardiac marker testing, including size; growth; industry trends; product development and investment; and clinical measurement devices, reagents and supplies. Highly-attractive cardiac marker areas of growth covered in this review include: the cardiac rapid assay market, troponins, Creatine kinase-myocardial band (CK-MB) and brain natriuretic peptide (BNP) testing. Also examined are heart failure, myoglobin, homocysteine (Hcy), C-reactive protein (CRP), pulmonary embolism (PE) (D-dimer test), low-density and high-density lipoproteins (LDL and HDL), stroke, cardiac enzymes, albumin, cardiac markers used in clinical decisions, cardiac markers in renal failure, cardiac panels and point of care (POC) cardiac markers. This study also provides a thorough analysis of the companies known to be marketing, manufacturing or developing cardiac marker products in the U.S. and worldwide, as well as detailed tables, charts and figures covering the U.S., Europe and Asia markets.

Table of Contents :

1. Overview 7
1.1 Statement of Report 7
1.2 Objectives of This Report 7
1.3 Scope of This Report 9
1.4 Methodology 9
1.5 Executive Summary 10

2. Introduction 13
2.1 Global Diagnostic Products Industry 13
2.2 Barriers to Entry 17
2.3 Company Evaluation Overview 17
2.4 Market Outlook 18
2.5 Technologies and Products that are the Most Successful in the New IVD
Environment 19

3. Cardiac Marker Testing Markets: Market Segment Analysis: Size, Growth and
Share 20
3.1 Global Cardiac Marker Diagnostic Testing Markets 20
3.1.1 Clinical Utility of Cardiac Markers 25
3.1.2 Market Drivers in the Cardiac Marker Diagnostics Testing Sector 26
3.1.3 Market Restraints in Cardiac Marker Testing Segment 27
3.1.4 Principal Market Segments for Cardiac Marker Testing 27
3.1.5 Key Players in the Cardiac Marker Diagnostics Testing Segment 27
3.1.6 Cardiac Marker Testing Sector Analysis 28
3.2 U.S. Cardiac Marker Testing Market 29
3.2.1 Market Overview 29
3.2.2 Diagnostic Test Categories 30
3.2.3 U.S. Hospital POC Cardiac Markers 30
3.3 European Cardiac Marker Diagnostic Test Market 32
3.3.1 German Diagnostic Markets 34
3.3.2 U.K. Diagnostic Testing Market 36 U.K. Market Statistics 36 U.K. Competitive Analysis 37 U.K. Market Access 38
3.3.3 Italy 38
3.3.4 France 38
3.3.5 Spain 39
3.3.6 Belgium 39

More Related Reports :

  Breast Cancer Therapies Markets

  HIV-AIDS Testing Markets

  Over-the-Counter Diagnostic Products World Markets

  DNA Sequencing and PCR Markets

  Medical Imaging Markets

  Clinical Laboratory Testing Volume 2: Key Players for Laboratory Testing, Business Trends and Strategies

  Clinical Laboratory Testing Volume 1: IVD Reagents and Instruments Markets

  Diabetes, Metabolic Syndrome and Cardiovascular Disease

  Catheter Markets

  Blood Glucose Testing and Diabetes Management

  Global Flow Cytometry Market

  U.S. Glucose Testing Markets

For More details about above & other Reports plz contact :


Contact: Marketing team




You can also request for sample page of above mention reports on